Author: NewsCancer

A scientist whose wife has incurable cancer transforms images of breast cancer cells into artworks.

Heart disease remains one of the leading causes of death worldwide, responsible for about 20 million deaths each year and roughly a quarter of all deaths in the UK. Statins are widely prescribed medications that reduce LDL (“bad”) cholesterol and are proven to lower the risk of heart attacks, strokes, and other cardiovascular problems. Despite their strong track record, concerns about possible side effects have led some patients to hesitate or stop treatment. To better understand the true risks, researchers analyzed data from 23 major randomized studies conducted by the Cholesterol Treatment Trialists’ Collaboration. This included 123,940 participants in 19…

Mantle cell lymphoma (MCL) remains a challenging and rare disease, driving oncologists and researchers to continually seek optimal sequencing and combination strategies for novel agents. To address these critical, global questions, the Lymphoma Research Foundation hosted the2025Mantle Cell Lymphoma Scientific Consortium and Workshop, a vital international forum where physicians from around the globe come together to share cutting-edge data, align on research goals, and foster collaboration to avoid pitfalls in clinical trial design.Julie M. Vose, MD, MBA, spoke with CancerNetwork® to discuss the major takeaways and future directions highlighted at the most recent workshop. Vose emphasized that this collaborative approach…

London, UK – February 19, 2026BETHESDA, Md., Feb. 13, 2026 /PRNewswire/ – Precision Biologics, Inc. CEO Philip M. Arlen, MD gives a Keynote presentation describing in vitro and in vivo efficacy of its novel tumor-specific antibody-drug-conjugate PB-223 ADC (PB-vcMMAE-5).  Recent tumor killing data showing specific non-toxic anti-tumor activity in several human cancer types expressing truncated core 2 O-glycans will be reported in  “PB-223, A Novel Antibody Drug Conjugate Targeting Truncated Core-2 glycans in Solid Tumors”, at the 6th Ace Drug Discovery Summit, The Insurance Hall, London, UK, February 18-19, 2026. “The exquisite sensitivity and specificity of our recently developed mAb enables maximum anti-tumor response to our…

Actor James Van Der Beek died on 11 February, aged 48; he had been diagnosed in 2023 with colorectal cancer.According to the World Health Organization, colorectal cancer is the third most common cancer and the second leading cause of cancer-related deaths worldwide. While rates are declining overall, cases among younger people are rising.“This is a curable cancer if diagnosed early,” says Dr Deirdre Cohen, director of the gastrointestinal oncology program for the Mount Sinai health system and an associate professor of medicine. “It’s important to bring any symptoms to the attention of your physician.”Here’s what you need to know about…

John Hargreaves says he “dreams” about being able to go to the shops or down by the canal.

Pancreatic cancer is one of the most difficult cancers to diagnose early, and it often does not respond well to standard treatments. Because of this, scientists are searching for new ways to stop the disease before it advances. Researchers already understand that nerves can help cancer spread, but what happens in the earliest phases of pancreatic cancer has remained uncertain. “One phenomenon that is known is called perineural invasion,” says Jeremy Nigri, a postdoc in Professor David Tuveson’s lab at Cold Spring Harbor Laboratory (CSHL). “This means cancer cells will migrate within the nerve and use the nerve as a…

Receiving an mRNA COVID-19 vaccine shortly before or at any point during pregnancy is not linked to autism or other developmental disorders in children, according to research presented at the Society for Maternal-Fetal Medicine (SMFM) 2026 Pregnancy Meeting. The findings provide new data on the long term health of children whose mothers were vaccinated around the time of pregnancy. In the United States, two types of COVID-19 vaccines are recommended: the messenger ribonucleic acid (mRNA) vaccine and a protein subunit vaccine. Both are considered safe during all stages of pregnancy and are recommended to help safeguard both maternal and infant…

The PRECEDE Consortium provides a standardized, large-scale infrastructure for the early detection of pancreatic cancer, addressing a clinical landscape where five-year survival rates have remained stagnant at 13%, according to Diane Simeone, MD. This 13% 5-year survival rate was noted in a study published by American Cancer Society, which also showed that across all combined cancer types, the 5-year survival rate was 70%.1By prioritizing global data sharing over traditional academic silos, the PRECEDE Consortium aims to shift the diagnosis of pancreatic cancer toward earlier, resectable stages. The consortium was stablished as a response to the failure of previous individual-led strategies…